{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:36Z","timestamp":1792184676636,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jaac.2015.01.008","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T20:35:34Z","timestamp":1422477334000},"page":"283-293","source":"Crossref","is-referenced-by-count":99,"title":["A Randomized, Placebo-Controlled Study of Duloxetine for the Treatment of Children and Adolescents With Generalized Anxiety Disorder"],"prefix":"10.1016","volume":"54","author":[{"given":"Jeffrey R.","family":"Strawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Pangallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E.","family":"Stroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Findling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2015.01.008_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.psc.2009.06.002","article-title":"Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V","volume":"32","author":"Beesdo","year":"2009","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.jaac.2015.01.008_bib2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","article-title":"Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication\u2014Adolescent Supplement (NCS-A)","volume":"49","author":"Merikangas","year":"2010","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archgenpsychiatry.2011.160","article-title":"Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement","volume":"69","author":"Kessler","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders Text Revision","year":"2000"},{"key":"10.1016\/j.jaac.2015.01.008_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","article-title":"The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders","volume":"55","author":"Pine","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archgenpsychiatry.2009.177","article-title":"Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder","volume":"67","author":"Beesdo","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/00004583-200109000-00018","article-title":"Life course outcomes of young people with anxiety disorders in adolescence","volume":"40","author":"Woodward","year":"2001","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.63.9.1017","article-title":"Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study","volume":"63","author":"Foley","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1176\/appi.ps.201200058","article-title":"Twelve-month suicidal symptoms and use of services among adolescents: results from the National Comorbidity Survey","volume":"63","author":"Husky","year":"2012","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2015.01.008_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/da.20039","article-title":"Child anxiety in primary care: prevalent but untreated","volume":"20","author":"Chavira","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jaac.2015.01.008_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chc.2012.05.003","article-title":"Psychopharmacologic treatment of children and adolescents with anxiety disorders","volume":"21","author":"Strawn","year":"2012","journal-title":"Child Adolesc Psychiatr Clin North Am"},{"key":"10.1016\/j.jaac.2015.01.008_bib12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","article-title":"Fluvoxamine for the treatment of anxiety disorders in children and adolescents","volume":"344","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2015.01.008_bib13","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2015.01.008_bib14","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","article-title":"Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder","volume":"158","author":"Rynn","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/ajp.2007.164.2.290","article-title":"Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials","volume":"164","author":"Rynn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1037\/a0025933","article-title":"Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS","volume":"79","author":"Ginsburg","year":"2011","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1016\/j.jaac.2015.01.008_bib17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jpsychires.2010.12.007","article-title":"The diagnostic threshold of generalized anxiety disorder in the community: a developmental perspective","volume":"45","author":"Beesdo-Baum","year":"2011","journal-title":"J\u00a0Psychiatric Res"},{"key":"10.1016\/j.jaac.2015.01.008_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/104454602760386879","article-title":"Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study","volume":"12","year":"2002","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2015.01.008_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/da.21913","article-title":"Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder","volume":"29","author":"Strawn","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jaac.2015.01.008_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/14737175.9.2.155","article-title":"Duloxetine in the treatment of generalized anxiety disorder","volume":"9","author":"Kornstein","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jaac.2015.01.008_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/cap.2011.0072","article-title":"An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression","volume":"22","author":"Prakash","year":"2012","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2015.01.008_bib22","unstructured":"Cymbalta Full Prescribing Information. Available at: http:\/\/pi.lilly.com\/us\/cymbalta-pi.pdf. Accessed December 1,\u00a02014."},{"key":"10.1016\/j.jaac.2015.01.008_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/cap.2013.0096","article-title":"A\u00a0double-blind, efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder","volume":"24","author":"Emslie","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2015.01.008_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/cap.2013.0146","article-title":"A\u00a0double-blind, efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder","volume":"24","author":"Atkinson","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2015.01.008_bib25","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00004583-200209000-00006","article-title":"The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties","volume":"41","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","article-title":"Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)","volume":"71","author":"Sheehan","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib27","series-title":"ECDEU assessment manual for psychopharmacology","first-page":"217","author":"Guy","year":"1976"},{"key":"10.1016\/j.jaac.2015.01.008_bib28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A\u00a0children\u2019s Global Assessment Scale (CGAS)","volume":"40","author":"Shaffer","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","article-title":"Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA\u2019s pediatric suicidal risk analysis of antidepressants","volume":"164","author":"Posner","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib30","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib31","series-title":"The Prevention and Treatment of Missing Data in Clinical Trials. Panel on Handling Missing Data in Clinical Trials. Committee on National Statistics, Division of Behavioral and Social Sciences and Education","year":"2010"},{"key":"10.1016\/j.jaac.2015.01.008_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaac.2012.10.006","article-title":"Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale","volume":"52","author":"Caporino","year":"2013","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib33","article-title":"Antidepressant efficacy and tolerability in pediatric anxiety disorders: a systematic review and meta-analysis","author":"Strawn","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jaac.2015.01.008_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/appi.ajp.2008.08020247","article-title":"Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder","volume":"166","author":"Bridge","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A\u00a0model of placebo response in antidepressant clinical trials","volume":"170","author":"Rutherford","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2015.01.008_bib36","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2015.01.008_bib37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.psy.0000138133.72365.45","article-title":"Blood pressure and cerebrospinal fluid norepinephrine in combat-related posttraumatic stress disorder","volume":"66","author":"Strawn","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jaac.2015.01.008_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1126\/science.7466370","article-title":"Essential hypertension: central and peripheral norepinephrine","volume":"211","author":"Lake","year":"1981","journal-title":"Science"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856715000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856715000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:50:25Z","timestamp":1537905025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856715000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0890856715000386"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2015.01.008","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}